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Abstract 
Background and aims: Observational studies show a peak incidence of cardiovascular 
events after major surgery. For example, the risk of myocardial infarction increases 25-fold 
early after hip replacement. The acuteness of this increased risk suggests abrupt 
enhancement in plaque vulnerability, which may be related to intra-plaque inflammation, 
thinner fibrous cap and/or necrotic core expansion. We hypothesized that acute systemic 
inflammation following major orthopedic surgery induces such changes. 
Methods: ApoE-/- mice were fed a western diet for 10 weeks. Thereafter, half the mice 
underwent mid-shaft femur osteotomy followed by realignment with an intramedullary K-wire, 
to mimic major orthopedic surgery. Mice were sacrificed 5 or 15 days post-surgery (n=22) or 
post-saline injection (n=13). Serum amyloid A (SAA) was measured as a marker of systemic 
inflammation. Paraffin embedded slides of the aortic root were stained to measure total 
plaque area and to quantify fibrosis, calcification, necrotic core, and inflammatory cells.  
Results: Surgery mice showed a pronounced elevation of serum amyloid A (SAA) and 
developed increased plaque and necrotic core area already at 5 days, which reached 
significance at 15 days (p=0.019; p=0.004 for plaque and necrotic core, respectively). 
Macrophage and lymphocyte density significantly decreased in the surgery group compared 
to the control group at 15 days (p=0.037; p=0.024, respectively). The density of neutrophils 
and mast cells remained unchanged. 
Conclusions: Major orthopedic surgery in ApoE-/- mice triggers a systemic inflammatory 
response. Atherosclerotic plaque area is enlarged after surgery mainly due to an increase of 
the necrotic core. The role of intra-plaque inflammation in this response to surgical injury 
remains to be fully elucidated. 
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Introduction 
Observational epidemiological studies have confirmed what experienced clinicians suspected 
for many years: cardiovascular events can be triggered by a variety of common non-
cardiovascular clinical conditions, particularly those that are associated with systemic 
inflammation 1-3. One of the best documented examples of non-infectious systemic 
inflammation causing an acute increase in cardiovascular risk is major surgery. A recent 
study indicated that the risk of myocardial infarction in patients undergoing total hip or knee 
replacement is increased by no less than 25 fold, mainly during the first days to weeks post-
surgery 2. This phenomenon is hardly investigated and the mechanisms which underlie this 
postoperative risk remain elusive.  
The acuteness of the increased postoperative cardiovascular risk suggests an effect on 
atherosclerotic plaque stability 4. Several studies indeed show that at least half of the cases 
of myocardial infarction following non-cardiac surgery originate from rupture of unstable 
plaques 5-7. Why plaques could become more prone to rupture briefly after surgery is unclear. 
Plaque instability is not only related to factors such as fibrous cap strength and intra-plaque 
hemorrhage, but also to the necrotic core area which, in turn, are all influenced by intra-
plaque inflammation 8-11.  
Plaque area was shown to increase in mice after a single injection of serum amyloid A 
peptide, a marker and mediator of inflammation12 . A recent study addressing the combined 
effects of major blood loss and surgery reported increased plaque size growth as well as 
increased plaque vulnerability already after 72 hours 7. Major orthopedic surgery is known to 
cause massive systemic inflammation 13. We therefore hypothesized that acute systemic 
inflammation caused by major orthopedic surgery could rapidly enhance plaque vulnerability 
by means of increased intra-plaque inflammation, fibrous cap thinning and/or necrotic core 
expansion, and we addressed this hypothesis in atherosclerosis-prone ApoE-/- mice. 
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Materials and methods  
Mouse model  
ApoE-/- mice (9-10 weeks old) were obtained from Charles River Laboratories (Calco 
Como,Italy) and housed in specific pathogen-free rooms, on a 12-h light–dark cycle. All mice 
were fed a high-fat diet (0.15 % cholesterol) (4022.83, AB diets, Woerden, the Netherlands) 
for 10 weeks after which the surgery group underwent a mid-shaft femur osteotomy followed 
by realignment with an intramedullary K-wire, to mimic major orthopedic surgery. Under 
general anesthesia (2% isoflurane) and analgesia (0.1 mg/kg buprenorfine), the femur was 
accessed via a lateral skin incision of the greater trochanter just proximal of the knee joint. 
The femur was approached using microsurgical scissors and forceps. With a dental mini-
cutter, a mid-shaft osteotomy was performed. After that a stainless steel 0.6 mm K-wire 
(DePuy Synthes, Amersfoort, The Netherlands) was retrogradely introduced into the medulla 
of the femur until it exited medial and proximal of the greater trochanter. This was done using 
an electrical rotary system (Model 3000, Dremel, Breda). The osteomy was reduced and the 
osteotomy was stabilized by normogradely introducing the K-wire into the medulla of the 
distal femur until seated in the distal metaphysis. The K-wire was cut flush with the 
trochanter, where after the wound was closed by interrupted sutures (Monocryl 5-0 FS-2, 
Eticon) for both the femoral fascia and skin. During the operation bleeding was kept to a 
minimum by using bipolar radiofrequency micro-forceps (Pfizer, Valleylab Force 30). Blood 
was sampled after a 4-hour fasting period at several time points surrounding surgery/control 
(t=-1 day, 1 day, 5 days and 15 days). Mice in both operation (n=22) and control group 
(n=13) were sacrificed 5 or 15 days post-surgery respectively post-saline injection. All 
procedures were approved by the Animal use and care Committee at the VU University 
Medical Centre of Amsterdam.  
 
Analysis of systemic inflammation and serum lipids  
Levels of serum amyloid A (SAA), soluble VCAM-1 (CD106) and soluble E-selectin (CD62E) 
were measured by ELISA (Life Technologies, Bleiswijk, the Netherlands for SAA and R&D 
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Systems, Abingdon, UK, for VCAM-1 and E-selectin). Total serum cholesterol and 
triglyceride levels were measured in serum by commercially available enzymatic assays 
(cholesterol CHOD-PAP 11491458 and triglycerides GPO-PAP 11488872, Roche, Woerden, 
the Netherlands). For determination of the lipid profile, pooled plasma per group was 
fractionated using an ÅKTA fast protein liquid chromatography system (Pharmacia, 
Roosendaal, the Netherlands). Fractions were collected and assayed for total cholesterol 
using an enzymatic assay cholesterol CHOD-PAP 11491458 (Roche) and analysed as 
reported 14. 
 
(Immuno)histochemistry and morphometry  
Dissected hearts including the aortic roots were embedded in paraffin after overnight fixation 
(4 % formalin) for analysis of atherosclerosis. Serial cross-sections (4 µm) directly distal to 
the valve area of the aortic root were stained with Alcian Blue (indicative of 
glycosaminoglycans), Elastica van Gieson, Von Kossa and MAC-3, scanned with a 
PathScan Enabler IV, after which the mean surface area of plaque and the concordant area 
of fibrosis (EVG), calcification (Von Kossa) and macrophage area (MAC-3) was analysed 
blindly from each specimen using QuickPHOTO MICRO 3.0 software or in the case of the 
MAC-3 staining and the fibrous cap thickness15 with ImageJ software. The necrotic core area 
was calculated by subtracting the area of fibrosis, calcification and macrophages from the 
total plaque area. For immunohistochemical analysis, serial cross-sections were dewaxed, 
rehydrated and incubated in methanol/H2O2 (0.3%) for 30 minutes to block endogenous 
peroxidases. Antigen retrieval was performed using pepsin for 25 minutes at 37 °C (Ly-6G 
and CD206), boiling in Tris-EDTA buffer, pH 9.0 (Caspase-3) or in citrate buffer, pH 6.0, for 
15 minutes at 100 °C using a microwave (MAC-3 and i NOS). Sections were incubated with 
normal rabbit serum (1:50 dilution, DAKO, X0902) for 10 minutes at room temperature (RT) 
and subsequently with the primary antibody using rat-anti-mouse-MAC-3 antibody, detecting 
macrophages (1:30 dilution, BD Pharmingen, clone M3/84, cat. 553322, overnight, RT) or 
rat-anti-mouse-Ly6G antibody (detecting neutrophilic granulocytes) (1:200 dilution, BD 
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Pharmingen, clone 1Ab, cat. 551459, 1 hour, RT) as appropriate. Thereafter, sections were 
incubated with biotinylated rabbit-anti-rat (1:300 dilution, DAKO, E0468, 30 minutes)/ 
Streptavidin-HRP (1:100 dilution, DAKO, P0397, 1 hour). For iNOS staining (to detect type 1 
macrophages) the primary antibody polyclonal rabbit-anti-iNOS (1:200 dilution, Abcam, 
Ab15323, 1 hour, RT) was used and for the Caspase-3 (apoptosis marker) the primary 
antibody polyclonal Rabbit-anti-Caspase-3 (1:500 dilution, cell signaling technology, cat. 
9661-L, 1 hour, RT) was used. Both were followed by incubation with HRP labeled anti-rabbit 
(100 µl undiluted, DAKO, K4003) for 30 minutes. For the CD206 staining (detecting type 2 
macrophages) the primary antibody polyclonal Rabbit-anti-mannose receptor CD206 (1:1000 
dilution, Abcam, Ab64693, 1 hour, RT) was used, followed by a swine anti-rabbit HRP 
secondary antibody (1:100 dilution, DAKO P0217, 30 minutes, RT). For CD45 staining 
(detecting lymphocytes), antigen retrieval was performed using citrate buffer, pH 6.0, for 15 
minutes at 100⁰C using a microwave. Sections were incubated in water (97°C) for 30 
minutes and subsequently incubated in methanol/H2O2 (0.3%) for 30 minutes. Afterwards, 
sections were incubated with rat-anti-mouse-CD45 antibody (1:50 dilution, BD Pharmingen, 
cat. 550539, overnight, 4°C), rinsed in PBS, incuba ted with rabbit-anti-rat-HRP (1:50 dilution, 
DAKO, P0450) for 30 minutes. All staining’s were visualized with 3,3-diamino-benzidine-
tetrahydrochloride/H2O2(DAB, 0.1 mg/ml, 0.02% H2O2) for 10 minutes and counterstained 
with haematoxylin. Mast cells were stained with Toluidine Blue 1%. MAC-3 area was 
quantified as percentage MAC-3 positive staining of the total plaque area, using an 
automated macro in ImageJ software. Numbers of Ly-6G and CD45 positive cells were 
manually quantified per surface area of the atherosclerotic plaque as cells/µm2. 
Immunoscoring was performed by R.L and W.W.F. and agreement was reached between 
both observers.  
 
Statistics  
Statistical analysis was performed with SPSS (20.0 for Windows, SPSS Inc.). To test for 
differences in plaque area, necrotic core area and inflammatory cells between groups, an 
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independent sample t-test was used when the data were normally distributed, or a Mann–
Whitney U test if not. All data are presented as median and interquartile range. Results were 
considered statistically significant if the two-sided p-value was <0.05.  
Results 
Surgery causes acute systemic inflammation 
To determine whether major orthopedic surgery was indeed accompanied by an acute 
systemic inflammatory response, we measured serum SAA levels at different time points (t=-
1 day, 4 hours, 1 day, 5 days and, in the late-sacrifice group, after 15 days) (Fig. 1A). SAA 
levels had increased 4 hours after surgery, increased by almost 100 fold after 24 hours, and 
returned to baseline levels within 5 days. In contrast, SAA values in the control group 
remained low and stable. Endothelial inflammation markers (VCAM-1 and E-selectin) did not 
increase in response to trauma (Fig. 1BC).  
 
Surgery transiently decreases body weight and alters lipid profile 
Mice in the surgery group had weight loss (6.6%) at 5 days compared to baseline, whereas 
control mice gained weight (5.8%). Serum cholesterol and triglyceride levels were measured 
at t=-1 day, 1 day, 5 days and, in the late-sacrifice group, after 15 days. We observed a 
transient lipid-lowering effect of surgery. This effect was relatively small for cholesterol (Fig. 
1D), but more pronounced for triglycerides (Fig. 1E). The lipoprotein profile for cholesterol 
distribution in VLDL, LDL and HDL-sized particles showed a slight reduction in VLDL which 
was paralleled by an equally small increase in LDL from t=5 days onward (Fig. 1F-I). 
 
Surgery does not increase the content of inflammatory cells within atherosclerotic lesions 
We observed a significant reduction (p=0.037) of the macrophage area relative to the total 
atherosclerotic plaque area between the surgery and control group at t=15 days (Fig. 2B). 
Subtyping of typical type 1 macrophages (M1 - iNOS positive area) and type 2 macrophages 
(M2 - CD206 positive area) relative to total macrophage area (MAC-3 positive area) was 
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performed (Fig. 2D,F). At t=5 days, a significantly lower M1 fraction was observed in the 
surgery group 44% [33-54] versus 55% [47-87] in the control group; p=0.028) which 
increased significantly to 80% [66-121] (p=0.007) at 15 days. The relative density of M2 
macrophages was not affected significantly. No significant differences were found between 
surgery and control mice in the number of neutrophilic granulocytes (Ly-6g) and mast cells 
(toluidine blue) (Fig. 2H and J). We did, however, observe a significant reduction in 
lymphocyte density (Fig. 2L) 15 days post-surgery as compared to the control group 
(p=0.024).  
 
Atherosclerotic plaque and necrotic core area increase after surgery 
Aortic root sections of all experimental groups showed advanced atherosclerotic lesions  
infiltrated by macrophages and lymphocytes, with a thin fibrous cap (Fig. 3A-D). To assess 
the effect of surgery, we measured total plaque area in the root, and evaluated the relative 
contribution of different plaque components. At t=5 days, a non-significant 5.5% higher 
plaque area was observed in the surgery group (481 x 103 µm2  [387-558] versus 456 x 103 
µm2 [394-491] in the control group; p=0.297). This difference became more pronounced and 
statistically significant at t=15 days; (519 x 103 µm2 [485-634] in operated mice versus 387 x 
103 µm2 [331-464] in control mice, p=0.019; Fig. 3E). This plaque enlargement was mainly 
attributable to a 160% increase in the necrotic core area (257 x 103 µm2 [151-315] in operated 
mice versus 99.0 x 103 µm2 [71.2-155] in control mice, p=0.004; Fig. 3F). The area of the 
other plaque compartments (fibrosis, macrophages, calcification and apoptosis) did not 
significantly contribute to the increase in plaque area (Fig. 4). Also, we found no evidence of 
fibrous cap thinning at t=5 days (28.7 [22.4-42.3] µm in operated mice versus 19.8 [17.5-
37.2] µm in control mice, p=0.3), nor at t=15 days (36.7 [29.6-45.2] µm in operated mice 
versus 24.5 [18.7-42.3] µm in control mice, p=0.6). In addition, we assessed old intra-plaque 
hemorrhage but only found small non-significant areas of Fe-positivity that had only a very 
minor contribution to the total area and that did not differ between groups (data not shown). 
Finally, in the roots of all mice (surgery and control) Alcian Blue positive staining was 
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observed both in the necrotic core area and in the other regions of the plaque, with no 
differences between the groups.  
 
Discussion 
Major orthopedic surgery in ApoE-/- mice causes acute systemic inflammation. At 15 days 
post-surgery, we observed a significant increase of plaque area, mainly due to necrotic core 
enlargement. Plaque necrosis is a characteristic hallmark of atherosclerotic lesions that 
causes acute atherothrombotic vascular disease 9-11. Our finding of a post-surgery increase 
of necrotic core area may reflect increased plaque vulnerability and could, at least partly, 
explain the increased incidence of cardiovascular events after major orthopedic surgery. 
The surgical procedure caused a marked acute systemic inflammatory response as 
demonstrated by a rapid increase in SAA, a relatively stable inflammation marker that 
integrates the signals of proatherogenic cytokines (IL1, TNFα, IL6), many of which may have 
contributed to the effect on the atherosclerotic leasion16, 17. Several studies suggest that SAA 
itself participates in the pathogenesis of atherosclerosis and a recent study shows that it may 
contribute to plaque vulnerability 18. For instance, SAA induces TGF-β, increases vascular 
biglycan content, and increases LDL retention 19. SAA also stimulates NF-κB activation and 
induces the expression of pro-atherosclerotic factors, such as ICAM-1, MCP-1, MMP-9 and 
tissue factor in macrophages 20. Lastly, SAA displaces apoA-I from the surface of the HDL 
particle, thus generating free apoA-I, which is cleared faster by the kidney, thus potentially 
affecting the anti-atherogenic effect of HDL21. In addition to the effects on SAA, we observed 
a slight effect on circulating lipoproteins (i.e. decrease in VLDL and increase in LDL) in the 
orthopedic surgery group. Although the shift toward more atherogenic particles is relatively 
small,  it may have contributed to the development of atherosclerosis in the orthopedic 
surgery group.   
We did not find indications of fibrous cap thinning after orthopedic surgery, which besides 
necrotic core expansion is another hallmark of vulnerable, inflammatory plaque8, 22. We 
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cannot exclude fibrous cap thinning because it is known to be very heterogeneously 
distributed, varying between and within lesions23. In parallel, we did not find an increased 
density of inflammatory cells after orthopedic surgery. This may have been caused by the 
fact that we examined plaques after 5 and 15 days. We cannot exclude inflammatory cell 
infiltration taking place before these time points and that activated macrophages in particular 
had already ‘dissolved’ at 5 days, contributing to the necrotic core. Indeed, death of lesional 
macrophages promotes the formation of plaque necrosis 9, and could thus be compatible 
with the decreased plaque macrophage content we observed at later time points. Similarly, 
activation of lymphocytes may cause loss of CD45-positive epitopes and cells can become 
undetectable by CD45-staining. It thus remains possible that surgery-induced intra-plaque 
inflammation due to infiltration of immune cells contributed to the observed increase in the 
necrotic core area (and hence total lesion area).  
There is a growing understanding that the balance between pro- and anti-inflammatory 
macrophages in plaque is dynamic. 24. We found an increase in the fraction of M1 pro-
inflammatory macrophages at 15 days, supporting a pro-inflammatory postoperative plaque 
milieu.  
We have found no differences between the different groups and time points for Caspase-3, 
an apoptosis marker, and therefore we cannot conclude that apoptosis is a major driver of 
the necrotic core expansion after surgery. Of note, however, these test also do not exclude a 
role for apoptosis. Caspase-3 staining is a temporary phenomenon in apoptosis and after 
some time, Caspase-3 staining in the necrotic core could be lost. This also emphasizes the 
need for future studies addressing earlier time points and more in-depth characterization of 
biomarker profile, and inflammatory cell activity in similar experimental designs.  
Several related experimental studies merit discussion. Recently, a study in ApoE-/- mice 
addressed the combined effects of major blood loss and surgery, and reported increased 
plaque size after 72 hours, along with signs of plaque vulnerability 7. However, this effect 
appeared to be mainly due to excessive blood loss (20% of body weight; which is 
substantially more than in our model), rather than surgery itself. As in our study, the density 
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of intra-plaque macrophages did not differ, but other inflammatory cell types were not 
quantified. A few experimental studies addressed the effects of acute systemic inflammation 
on atherosclerosis. A recent murine model of intra-abdominal sepsis suggested that 
atherosclerotic plaque area was enhanced by sustained systemic, endothelial and intimal 
inflammation, and was not explained by infection itself 25.  More specifically, an increase in 
intra-plaque macrophages was observed 5 months after the induction of sepsis via cecal 
ligation and puncture. This coincides with a sustained elevated level of IL6, suggesting that 
this model mimics a chronic inflammatory state, in contrast to our model of transient acute 
inflammation. No data on macrophage density at earlier time points (nor other inflammatory 
cell types) were reported. Another study in ApoE-/- mice showed that influenza virus infection 
caused subendothelial infiltration of a heterogeneous population of cells 26. These cells were 
however not quantified per type and plaque area was not assessed. Lastly a study again in 
ApoE-/- mice demonstrated that the systemic inflammatory response to myocardial infarction 
aggravates chronic atherosclerosis 22. Together with the results described herein, these 
studies support an important role for systemic inflammation in plaque destabilization and 
might thereby contribute to increased risk of cardiovascular events. 
Our study has the following limitations: our goal was to evaluate effects of major 
(orthopedic) surgery on atherosclerotic plaque. Although we found plaque changes 
congruent with increased event risk, the study wasn’t designed to clarify responsible 
mechanism(s). Our data are compatible with a role for surgery-induced inflammation, but this 
requires more in-depth studies. In addition, other, non- or indirect inflammatory effects of 
surgery could be further explored. For instance, hemodynamic disturbances 27, sympathetic 
nerve system activation 28 or enhanced platelet activity29 are potential contributors to 
atherosclerotic lesion development and increased cardiovascular risk. Furthermore it would 
be interesting to test our findings in advanced mouse models to study actual plaque 
complications rather than atherosclerotic plaque development alone 30, 31.  
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In conclusion, major surgery can cause a strong systemic inflammatory response and lead to 
an increase in plaque and necrotic core area, contributing to plaque vulnerability. These 
findings may help explain the high incidence of cardiovascular events following major surgery 
and, in a broader perspective, other clinical conditions of acute systemic inflammation.  
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Fig. 1. Major orthopedic surgery transiently increases serum SAA levels and 
decreases serum lipids. The vertical dotted line represents the timing of surgery. Serum 
levels of (A) SAA (µg/ml), (B) E-selectin (ng/ml), (C) VCAM-1 (µg/m), (D) cholesterol (mM), 
(E) triglycerides and (F-H) lipoprotein profile for cholesterol distribution in VLDL, LDL and 
HDL-sized particles at baseline and at different time points after surgery (n=22) or control 
(n=13). 
 
Fig. 2. MAC-3 positive area divided by total plaque area (%) at t=15 days post-surgery 
decreases. (A) MAC-3 positive area (encircled) in the plaque (B) divided by total plaque area 
(%).  (C) iNOS positive area (encircled) in the plaque (D) divided by MAC-3 positive area 
(%). (E) CD206 positive area (encircled) in the plaque (F) divided by MAC-3 positive area 
(%). (G) Ly-6g positive cells in the plaque (H) divided by the total plaque area (cells/µm2). (I) 
Toluidine blue stained cells in the adventitia (J) divided by the area of adventitia (cells/mm2). 
(K) CD45 positive cells in the plaque (L) divided by the total plaque area (cells/µm2). Arrows 
point out positive cells. P=plaque; L=lumen; Ad=adventitia. Magnification of A,C,E 10x; 
magnification G and K 40x; magnification I 50x. All expressed the aortic root of mice 
sacrificed at t=5 days post-surgery (n=12) or control (n=7) or t=15 days post-surgery (n=10) 
or control (n=6). 
 
Fig. 3. Major orthopedic surgery increases atherosclerotic plaque and necrotic core 
area. (A) Representative images of EVG stained cross-sections of the aortic root after 5 days 
without surgery, 5 days with surgery (B), 15 days without surgery (C), 15 days with surgery 
(D). All showing 10x magnified advanced atherosclerotic lesions (encircled) with necrotic 
cores (NC) and areas of fibrosis (F). The arrows indicate the media, the lumen (L) is largely 
composed of erythrocytes. (E) Plaque area (x103 µm2) and (F) necrotic core area (x103 µm2) 
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at the aortic root of mice sacrificed at t=5 days post-surgery (n=12) or control (n=7) or t=15 
days post-surgery (n=10) or control (n=6) . 
 
Fig. 4. Major orthopedic surgery shows no significant effect on area of fibrosis, 
macrophages and calcification. Plaque area (x 103 µm2) of fibrosis based on a EVG 
staining (A), macrophages based on a MAC-3 staining (B), calcification based on a Von 
Kossa staining (C) and apoptosis based on a caspase-3 staining (D) at the aortic root of mice 
sacrificed at t=5 days post-surgery (n=12) or control (n=7) or t=15 days post-surgery (n=10) 
or control (n=6) (all p-values >0.05). 
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Highlights 
• We hypothesized that the systemic inflammatory response following major orthopedic 
surgery causes increased plaque vulnerability expressed as local inflammation, 
plaque area and/or increased necrotic core area.  
• We found that major surgery causes a marked systemic inflammatory response and 
leads to an increase in plaque and necrotic core area.  
• These findings may help explain the high incidence of cardiovascular events following 
major surgery and, in a broader perspective, other clinical conditions of acute 
systemic inflammation.  
 
